Supplementary Fig. 2 from Pretargeted Anti-CD20 Radioimmunotherapy with scFv Fusion Protein Safely Combines with BEAM and ASCT in Patients with High-risk B-cell Lymphomas
Year: 2025
Type: supplementary-materials
Abstract: Development and FUnctional Validation of B9E9-FP
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4416903079
Cites:
Cited by:
Related to:
